BioBeers Message Board › Local Job Listings and Forum › The 2010 GoldLab Symposium - RSVP Now!
Closed to new replies
| Adam Rubenstein | |
|
|
Hello Friends and Colleagues. Here is a local event that you are not going to want to miss. Admission is ***FREE*** but seats are limited! Please RSVP at http://GoldLabSymposi...
2010 GoldLab Symposium – Time: The Crucial Fourth Dimension of Personalized Medicine GoldLab announces the upcoming GoldLab Inaugural Symposium 2010--Time: The Crucial Fourth Dimension of Personalized Medicine scheduled for Friday, May 14th and Saturday, May 15th 2010. During the US healthcare deliberations, the words invention, technology, diagnostics, and wellness were mentioned rarely, if ever. No one said “revolution in healthcare” and yet a healthcare revolution is underway. Never before could a physician peer into the body, blood, or DNA of a patient and “see” the risk of disease for that person or “see” a disease at such an early stage that intervention might be crucial. That vision defines Personalized Medicine, which includes actionable measurements of genotype and phenotype - DNA and proteins. For the Inaugural Symposium we have invited medical and scientific thought leaders and stakeholders to debate and inform each other and the audience. The goal is to facilitate the most timely transformation of medicine. “Our motivation is simple,” said Dr. Larry Gold, Professor, MCDB, University of Colorado and CEO of SomaLogic, “Scientists are responsible for innovations; scientists also must participate in discussions that enable the timely use of those innovations.” An informed citizenry is at the heart of an improved healthcare system. Speakers will include, but are not limited to: Larry Gold, Ph.D., Professor, University of Colorado and CEO, SomaLogic Fintan Steele, Ph.D., Director of Communications, Broad Institute Tom Cech, Ph.D., Professor, University of Colorado, former President, HHMI Larry Lasky, Ph.D., Partner, US Venture Partners, former Genentech Fellow Keith Gottesdiener, M.D., VP and Co-head of Late Stage Clinical Development, Merck Research Labs William Rom, M.D., MPH, Sol and Judith Professor of Medicine, Director of Pulmonary and Critical Care Medicine, New York University School of Medicine Steve Williams, M.D., Ph.D., CMO, SomaLogic George Poste, D.V.M., Ph.D., Chief Scientist, Complex Adaptive Systems Initiative Regents’ Professor and Del E. Webb Chair in Health Innovation Arizona State University Jay Wohlgemuth, M.D., Vice President of Science & Innovation, Quest Diagnostics Donald Jones, Vice President, Business Development, QUALCOMM David Snow, CEO, Medco Scott Danielson, Chief Experience Architect, Idea Couture Pat Furlong, Founding President and CEO, Parent Project Muscular Dystrophy (PPMD) Richard D. Lamm, Professor, Director of the Center for Public Policy & Contemporary Issues, University of Denver, former Governor of Colorado Daniel Kracov, Partner, Arnold and Porter David Rosenman, M.D., Mayo Clinic Richard A. Spritz, M.D., Professor of Pediatrics and Biochemistry and Molecular Genetics, University of Colorado, Denver Details and to RSVP visit: http://GoldLabSymposi... And… http://LinkedIn.GoldL... http://Facebook.GoldL... http://Twitter.GoldLa... |